Fermenta Biotech undertakes partial shutdown of manufacturing facility at Dahej

06 Oct 2021 Evaluate

Fermenta Biotech is undertaking a planned partial shutdown of its manufacturing facility at Dahej to carry out capacity increasing measures for Vitamin D3 crystals with effect from October 5, 2021 for an estimated period of 15 days, until October 20, 2021.

Following the previous shutdown in April 2019, which was successfully completed to increase capacity of Vitamin D3 intermediates, the current shutdown is being taken for increasing Vitamin D3 crystals' capacity. Post completion, the company’s production capacity of Vitamin D3 crystals will increase by around 25%. This initiative is part of company’s capacity enhancement strategy to meet the expected increase in peak demand for Vitamin D3 crystals under the current circumstances.

Fermenta Biotech (formerly known as DIL) is engaged in the business of research support services through their subsidiary Research Support International Ltd. (RSIL), manufacture and marketing of enzymes and chemicals through their subsidiary Fermenta Biotech (FBL).

Fermenta Biotech Share Price

333.20 9.30 (2.87%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×